Congratulations to Michele Curatolo’s FIBMET Study funding

Principal Investigators Michele Curatolo and Daniel Raftery have received notice of award for a project for 3 years from collaborator Merck & Co., Inc. Total award amount: $1,961,076. Title: Metabolomics profiles of chronic low back pain and fibromyalgia...